Pharma may see recovery with FY19 profit set to jump 20-22%: Crisil
This will be primarily on the back of strong growth in the overseas market, particularly in the regulated markets of the US and the EU, it said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals